醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
REGN · REGENERON PHARMACEUTICALS, INC.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
REGENERON PHARMACEUTICALS, INC.（REGN）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $6.6M；高管董事有效買入 —、有效賣出 —。最近申報 2026-10-15。
買入 Bought—
賣出 Sold$6.6M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-14 | MURPHY ANDREW J Co-Chief Scientific Officer | 賣出 Sell | 4,147 | $772.70 | $3.2M | SEC |
| 2026-09-02 | Guarini Kathryn Director | 賣出 Sell | 400 | $850.00 | $340K | SEC |
| 2026-09-02 | McCourt Marion EVP Commercial | 賣出 Sell | 2,346 | $853.56 | $2.0M | SEC |
| 2026-08-10 | Guarini Kathryn Director | 賣出 Sell | 400 | $800.00 | $320K | SEC |
| 2026-08-10 | Zoghbi Huda Y Director | 賣出 Sell | 800 | $800.00 | $640K | SEC |
| 2026-07-02 | RYAN ARTHUR F Director | 賣出 Sell | 200 | $650.15 | $130K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-10-14 | MURPHY ANDREW J Officer | 4,147 | $3.2M | 10b5-1 |
| 2026-09-03 | McCourt Marion Officer | 1,131 | $969K | 10b5-1 |
| 2026-09-02 | McCourt Marion Officer | 1,215 | $1.0M | 10b5-1 |
| 2026-09-02 | Guarini Kathryn Director | 400 | $340K | 10b5-1 |
| 2026-08-10 | Zoghbi Huda Y Director | 800 | $640K | 10b5-1 |
| 2026-08-10 | Guarini Kathryn Board member | 400 | $320K | 10b5-1 |
| 2026-07-02 | RYAN ARTHUR F Director | 400 | $250K | 10b5-1 |
內部人 Insiders
MURPHY ANDREW J、Guarini Kathryn、McCourt Marion、Zoghbi Huda Y、RYAN ARTHUR F